$AMCR

Why is Amcor stock sliding today?

Amcor shares fell 0.2% after hours to $46.45 after fiscal Q4 results. Adjusted diluted EPS was $1.23, above $1.19 consensus, and revenue was $6.4B versus about $6.05B. Full-year free cash flow was $1.3B, about $200M below guidance due to working capital. Transition EPS guidance was $1.80–$1.90. RBC set a Hold; UBS had a Buy and $56 target.

Original reporting
Published Aug 12, 2026, 9:42 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 10:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AMCR
Bearish
medium confidence
Mentioned
$AMCR
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AMCRBearishMed
01

Why it matters

Amcor’s headline EPS and revenue beat was outweighed by a free cash flow shortfall versus guidance and a cautious transition-period EPS range, plus a same-day RBC Hold rating.

02

Market read

Traders can treat this as a cash-flow and guidance repricing event for AMCR, not a simple earnings beat story.

03

What to watch

The article does not quantify segment margin trends or the specific working-capital drivers, which could change the interpretation of whether the FCF miss is recurring.

Relevance 7/10Novelty 6/10Timing: after-hours and pre-market earnings reaction today

Background

The piece frames Amcor’s move around its fiscal Q4 results released before the open, with investors reacting to cash flow and guidance details.

Company-level read

Ticker impact

$AMCRBearishMedium confidence
Context

Amcor reported fiscal Q4 EPS and revenue beats, but full-year free cash flow missed guidance by about $200 million and transition-period EPS guidance left limited upside.

Expected impact

Near-term downside bias as investors reprice free-cash-flow durability and transition-period visibility; any relief likely requires clearer FCF recovery signals.

Evidence & confidence

The article cites a specific FCF shortfall versus guidance, a constrained transition EPS range, and a fresh Hold rating, all occurring with the earnings release that drove the intraday selloff.

Market effects

Highlights that packaging investors are prioritizing free cash flow and forward visibility over top-line growth, which can pressure sector sentiment on similar prints.

Limited incremental impact noted, with S&P 500 flat and Nasdaq modestly lower.

No direct global macro or cross-border catalyst beyond the US CPI context, which was broadly in line.

Counterpoint

The EPS and revenue beats could still support the stock if investors view the working-capital-driven FCF dip as temporary rather than structural.

Key entities

  • Amcor

    Global packaging company whose fiscal Q4 results and transition-period guidance drove the stock’s decline.

  • RBC Capital

    Assigned a Hold rating on the day of the earnings release, adding caution.

  • UBS

    Initiated coverage with a Buy rating and a $56 price target the prior day.

Related articles

$AMCRMed

Berry deal supersizes Amcor

Amcor's acquisition of Berry Global boosted its full-year sales to $23.5bn, up 57%, and EBITDA to $3.67bn, up 68%. Net income more than doubled to $1.1bn. The deal made Amcor the world's largest packaging business, with significant growth in folding carton and flexible packaging divisions.

$AMCRMed

Amcor Q4 adjusted profit soars 40% on Berry integration

Amcor reported Q4 2026 adjusted net income of $570m, up 40% year over year, citing integration of Berry. Quarterly net sales rose to $6.39bn (+26%). Adjusted EBIT was $836m (+37%). For FY ended June 30, adjusted net income was $1.8bn (+64%) and net sales $23.5bn (+57%). Amcor also plans a calendar-year reporting change.

$AMCRMedAI 8/10

Amcor plc Q4 2026 Earnings Call Summary

Amcor plc reported Q4 2026 progress toward positive volume growth and said it delivered $285 million in fiscal 2026 synergies, exceeding year-one expectations. It projects adjusted EPS of $1.80 to $1.90 for a six-month transition period ending Dec. 31, 2026, and double-digit adjusted EPS growth in 2027. Free cash flow was $1.3 billion, below outlook, amid Middle East working-capital impacts.

$AMCRMedAI 8/10

Amcor (AMCR) Q4 2026 Earnings Call Transcript

Amcor (AMCR) reported Q4 2026 adjusted EPS of $1.23 (+23% y/y) and net sales of $6.4B (+26% reported), citing the Berry Global acquisition and higher raw material pass-through. FY revenue rose to $23.5B (+57%). Management reaffirmed a $650M three-year synergy target and guided adjusted EPS of $1.80 to $1.90 for the next six months.

$AMCRMedAI 8/10

Amcor Q4 Earnings Call Highlights

Amcor (NYSE:AMCR) reported Q4 results and discussed progress on its three-year synergy plan, saying it achieved about half of the $280 million target with nearly $140 million in new business awards. It reported FY free cash flow of $1.3B and expects 6-month adjusted EPS of $1.80 to $1.90. The board declared a $0.65 quarterly dividend.